0001209191-23-043531.txt : 20230727
0001209191-23-043531.hdr.sgml : 20230727
20230727162705
ACCESSION NUMBER: 0001209191-23-043531
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230725
FILED AS OF DATE: 20230727
DATE AS OF CHANGE: 20230727
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Randolph Sophia
CENTRAL INDEX KEY: 0001817127
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39386
FILM NUMBER: 231118836
MAIL ADDRESS:
STREET 1: C/O ALX ONCOLOGY HOLDINGS INC.
STREET 2: 866 MALCOLM ROAD, SUITE 100
CITY: BURLINGAME
STATE: CA
ZIP: 94010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALX ONCOLOGY HOLDINGS INC
CENTRAL INDEX KEY: 0001810182
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 850642577
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 323 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-466-7125
MAIL ADDRESS:
STREET 1: 323 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-07-25
0
0001810182
ALX ONCOLOGY HOLDINGS INC
ALXO
0001817127
Randolph Sophia
C/O ALX ONCOLOGY HOLDINGS INC.
323 ALLERTON AVENUE
SOUTH SAN FRANCISCO
CA
94080
1
1
0
0
Chief Medical Officer
0
Common Stock
2023-07-25
4
A
0
34000
A
315477
D
Common Stock
5.86
2023-07-25
4
A
0
107000
0.00
A
2033-07-24
Common Stock
107000
107000
D
The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on December 28, 2023.
Shares subject to the option vest in 48 equal monthly installments beginning on August 3, 2023.
/s/ Peter Garcia, by power of attorney
2023-07-27